News
2don MSN
A pilot study from Michigan Medicine researchers found that the Mediterranean diet may provide symptom relief for people with ...
12h
Health on MSNWhat Is the Difference Between IBS and Colon Cancer?Medically reviewed by Jay N. Yepuri, MD Irritable bowel syndrome (IBS) and colon cancer are conditions that affect the colon, ...
These painful spasms may be caused by irritable bowel syndrome (IBS). Two in three people with IBS are women—and scientists are still investigating why. “Hot girls have IBS.” This ...
In a comparative pilot study, the Mediterranean diet and the low FODMAP diet both provided relief for patients with IBS.
1d
India Today on MSNIrritable Bowel Disease is now an epidemic: Why India is seeing a surgeInflammatory bowel disease is increasing rapidly across India due to dietary and lifestyle changes. Doctors reveal how delayed diagnosis and social stigma are amplifying the challenges of effective ...
If you have symptoms of irritable bowel syndrome (IBS) and migraine but are trying to “tough it out” without a diagnosis or treatment plan, it’s time to reconsider. “Even though these ...
If you suffer from irritable bowel syndrome (IBS) and you feel an urgent need to go every time your boss pings you, your mother-in-law texts, or your friends change plans at the last minute ...
Gut-directed hypnotherapy reduces overall symptom burden and abdominal pain in those with irritable bowel syndrome, according to a recent study.
In the absence of registry data, it is impossible to know the precise incidence and prevalence of short bowel syndrome in the United States. On the basis of European data, the incidence of total ...
Researchers at Karolinska Institutet have identified three types of nerve cells connected to the intestinal villi, suggesting ...
J Gastroenterol Hepatol. 2013;28(1):73-77. Salivary IgA cannot be recommended as an investigation for gastrointestinal disease. Not only is the relationship between changes in IgA and ...
Ironwood Pharma has issued an upbeat assessment of phase 3 trial data with apraglutide for short bowel syndrome (SBS), but missed secondary outcome measures led to a sharp decline in its share price.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results